drugset / Trial / NCT00420095

A Study for Patients With Diabetes Mellitus (IOPA)

NCT00420095

Phase 4 Completed 117 enrolled Eli Lilly and Company
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare glycemic control (HbA1c) in Chinese patients with type 1 or type 2 diabetes when treated with insulin lispro low mixture and human insulin 30/70.

Timeline

Start
2007-01
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Human insulin 30/70 Unknown Subcutaneous
Subject Insulin Lispro Protein / enzyme biologic Subcutaneous